Form 4: Verrica Pharmaceuticals Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Christopher G. Hayes, Chief Legal Officer of Verrica Pharmaceuticals, sold shares of common stock to cover statutory tax withholding obligations related to the settlement of restricted stock units.
Summary
- Christopher G. Hayes, the Chief Legal Officer of Verrica Pharmaceuticals, sold shares of the company's common stock on July 22 and July 23, 2024.
- The sales were executed to cover statutory tax withholding obligations associated with the settlement of restricted stock units.
- On July 22, 2024, 21,649 shares were sold at a weighted average price of $7.06.
- On July 23, 2024, 91 shares were sold at a price of $6.98.
- Following these transactions, Hayes beneficially owns 141,486 shares of Verrica Pharmaceuticals' common stock.
Sentiment
Score: 5
Explanation: The document reflects a neutral event (stock sale for tax obligations) with no inherent positive or negative implications for the company's overall prospects.
Industry Context
This is a routine Form 4 filing related to insider stock sales to cover tax obligations, which is a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| 07/22/2024 | Sale of 21,649 shares of common stock at a weighted average price of $7.06. |
| 07/23/2024 | Sale of 91 shares of common stock at a price of $6.98. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.